Literature DB >> 21870915

Amblyopia and real-world visuomotor tasks.

Simon Grant1, Merrick J Moseley.   

Abstract

A question of increasing interest to the basic science and clinical management communities during the past decade is whether children and adults with amblyopia and associated binocular visual abnormalities experience difficulties in executing real-world actions, to which vision normally makes an important functional contribution. Here we provide objective evidence that they do, by reviewing quantitative data from a number of studies comparing their performance with that of matched normally sighted subjects on a range of everyday visuomotor tasks. Because in real life, these tasks (grasping objects, walking, driving, reading) are habitually performed with both eyes open, our focus is on their binocular skill deficits, rather than those with their amblyopic eye alone. General findings are that individuals with abnormal binocularity show impairments in critical aspects of motor control--movement speed, accuracy or both--on every one of these activities, the extent of which correlates with their loss of stereoacuity, but not the severity of their amblyopia. Impairments were especially marked when the task was time-limited or novel. Implications are that children and adults with severely reduced or absent binocularity may be accident-prone when required to respond rapidly to unexpected situations and that amblyopia management should focus more attention on evaluating and restoring stereoacuity and stereomotion processing.

Entities:  

Mesh:

Year:  2011        PMID: 21870915     DOI: 10.3109/09273972.2011.600423

Source DB:  PubMed          Journal:  Strabismus        ISSN: 0927-3972


  39 in total

1.  "Global" visual training and extent of transfer in amblyopic macaque monkeys.

Authors:  Lynne Kiorpes; Paul Mangal
Journal:  J Vis       Date:  2015       Impact factor: 2.240

2.  Space perception of strabismic observers in the real world environment.

Authors:  Teng Leng Ooi; Zijiang J He
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-19       Impact factor: 4.799

Review 3.  Stereopsis and amblyopia: A mini-review.

Authors:  Dennis M Levi; David C Knill; Daphne Bavelier
Journal:  Vision Res       Date:  2015-01-29       Impact factor: 1.886

4.  Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment.

Authors:  Julia M Baker; Carolyn Drews-Botsch; Melissa R Pfeiffer; Allison E Curry
Journal:  J AAPOS       Date:  2019-02-12       Impact factor: 1.220

5.  Binocular amblyopia treatment with contrast-rebalanced movies.

Authors:  Eileen E Birch; Reed M Jost; Angie De La Cruz; Krista R Kelly; Cynthia L Beauchamp; Lori Dao; David Stager; Joel N Leffler
Journal:  J AAPOS       Date:  2019-05-16       Impact factor: 1.220

6.  High specificity of the Pediatric Vision Scanner in a private pediatric primary care setting.

Authors:  Reed M Jost; David Stager; Lori Dao; Scott Katz; Russ McDonald; Eileen E Birch
Journal:  J AAPOS       Date:  2015-12       Impact factor: 1.220

7.  Global motion perception is related to motor function in 4.5-year-old children born at risk of abnormal development.

Authors:  Arijit Chakraborty; Nicola S Anstice; Robert J Jacobs; Nabin Paudel; Linda L LaGasse; Barry M Lester; Christopher J D McKinlay; Jane E Harding; Trecia A Wouldes; Benjamin Thompson
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 8.  Amblyopia: New molecular/pharmacological and environmental approaches.

Authors:  Michael P Stryker; Siegrid Löwel
Journal:  Vis Neurosci       Date:  2018-01       Impact factor: 3.241

9.  Age- and stereovision-dependent eye-hand coordination deficits in children with amblyopia and abnormal binocularity.

Authors:  Simon Grant; Catherine Suttle; Dean R Melmoth; Miriam L Conway; John J Sloper
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-05       Impact factor: 4.799

Review 10.  Amblyopia and binocular vision.

Authors:  Eileen E Birch
Journal:  Prog Retin Eye Res       Date:  2012-11-29       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.